Similar Articles

  • Update on the management of venous thromboembolism

    John R. Bartholomew, MD
    • Cleveland Clinic Journal of Medicine December 2017, 84 (12 suppl 3) 39-46;
    • DOI: https://doi.org/10.3949/ccjm.84.s3.04

  • Management of venous thromboembolism in patients with active cancer

    Heloni M. Dave, MBBS and Alok A. Khorana, MD, FACP, FASCO
    • Cleveland Clinic Journal of Medicine February 2024, 91 (2) 109-117;
    • DOI: https://doi.org/10.3949/ccjm.91a.23017

    • The authors review the presentation and diagnosis of venous thromboembolism in patients with cancer and present an approach to treatment that aims to balance the bleeding risk from anticoagulation with the risk of recurrent thrombosis.

  • Update on antiobesity pharmacotherapy in adults: Current and emerging options

    Farah Ziyadeh, MD, Sara Saliba, MD, RD, Dania Salih Bacha, MD, Yael Mauer, MD, MPH, Marcio L. Griebeler, MD, DABOM and Bartolome Burguera, MD, PhD
    • Cleveland Clinic Journal of Medicine January 2026, 93 (1) 36-46;
    • DOI: https://doi.org/10.3949/ccjm.93a.24112

    • The authors review antiobesity medications that are currently available or under investigation and discuss how to personalize obesity treatment.

  • Management of lower-extremity venous thromboembolism: An updated review

    Farah Ziyadeh, MD and Yael Mauer, MD, MPH
    • Cleveland Clinic Journal of Medicine April 2024, 91 (4) 229-235;
    • DOI: https://doi.org/10.3949/ccjm.91a.22090

    • A review of the 2021 updated guidelines of the American College of Chest Physicians including risk factors, supportive management, choice of anticoagulation therapy, and treatment considerations.

  • Issues and controversies in venous thromboembolism

    Teresa L. Carman, MD and Bernardo B. Fernandez Jr., MD, FACP
    • Cleveland Clinic Journal of Medicine February 1999, 66 (2) 113-123;

    • Discussions and recommendations on nine issues in thromboembolism, not commonly addressed in most reviews.

  • What are the management considerations for venous thromboembolic events in patients with cirrhosis?

    Marie M. Plante, MD, BSN, RN, Emily B. Wolf, MD and Razvan M. Chirila, MD
    • Cleveland Clinic Journal of Medicine February 2024, 91 (2) 86-88;
    • DOI: https://doi.org/10.3949/ccjm.91a.23045

    • The authors review the current evidence on venous thromboembolic event (VTE) risk prediction in patients with cirrhosis, as well as VTE prophylaxis and anticoagulant therapy.

  • Emerging options with coxib therapy

    Mark J. Lema, MD, PhD
    • Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 1) SI-76-SI-84;

  • Preventing venous thromboembolism in surgical patients

    Amir K. Jaffer, MD and Franklin A. Michota Jr., MD
    • Cleveland Clinic Journal of Medicine March 2006, 73 (3 suppl 1) S88-S94;

  • Prevention of venous thromboembolism after surgery

    Franklin A. Michota, MD, FHM
    • Cleveland Clinic Journal of Medicine November 2009, 76 (10 suppl 4) S45-S52;
    • DOI: https://doi.org/10.3949/ccjm.76.s4.08

  • Optimizing diagnostic testing for venous thromboembolism

    Patrick Rendon, MD, Taylor Goot, MD, Allison E. Burnett, PharmD, PhC, CACP, Michael B. Streiff, MD and Jessica Zimmerberg-Helms, MD
    • Cleveland Clinic Journal of Medicine July 2017, 84 (7) 545-554;
    • DOI: https://doi.org/10.3949/ccjm.84a.16049

    • A thoughtful approach to diagnosing venous thromboembolism and screening for thrombophilic disorders.

Previous
Next